Number of Shares
1.14 Mil
Current Holdings Value*
$48.33 Mil
% of Portfolio
5.02%
Total Estimate Gain
$11.27 Mil
% of Total Estimate Gain
28.09%

Segantii Capital Management Ltd's Cerevel Therapeutics Holdings Inc Holding Summary

As of 2024-03-31, Segantii Capital Management Ltd held 1.14 Mil shares of Cerevel Therapeutics Holdings Inc(CERE), totaling $48.33 Mil. This investment constitutes 5.02% of their stock portfolio, and Segantii Capital Management Ltd now holds 0.63% of the outstanding Cerevel Therapeutics Holdings Inc(CERE) stock.

The initial trade took place in 2023Q4. And since then Segantii Capital Management Ltd has made 2 purchases of CERE, at an average price of $35.10, for a total of 1.14 Mil shares. Based on historical transaction data and CERE's current price of $44.96, Segantii Capital Management Ltd's estimated gain on his CERE holdings is $11.27 Mil, reflecting a 28.09% gain to date.

Segantii Capital Management Ltd CERE ($44.96) Holding Chart

Segantii Capital Management Ltd CERE ($44.96) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1